The Pathology Department was established simultaneously with the opening of our hospital on August 8, 1999. It is a clinical medical technology department that integrates medicine, education, and research. It is currently a high-level hospital construction department.
Precision, accuracy, high quality and efficiency "is the quality policy of the pathology department. In May 2022, it passed the on-site evaluation of ISO15189 by the China National Accreditation Service for Conformity Assessment (CNAS), becoming the first pathology department in Shenzhen, the second in South China, and the 15th in the country to pass this accreditation. This marks the department's technical ability and diagnostic level to conduct examinations according to internationally recognized standards, providing patients with more accurate, efficient, and homogeneous medical services.
The pathology department currently has 37 medical technicians with a reasonable structure. Among them, there are 3 senior students, 7 associate senior students, 12 intermediate students, and 15 junior students. The department attaches great importance to talent cultivation. In addition to close communication with the Beijing Medical University system, it also sends personnel to famous domestic and foreign universities for training, draws on the strengths of others, and builds a high-quality team.
The department is equipped with advanced equipment, including 5 fully automatic dehydration machines, 4 embedding machines, 7 slicing machines, 2 fully automatic staining sealing machines, 1 fully automatic sealing machine, 2 frozen slicing machines, 4 sets of fully automatic immunohistochemical staining systems, 31 system microscopes (including 1 microscope for 11 people to view together, 1 microscope for 5 people to view together, and 4 microscopes for 2 people to view together), 1 fluorescence microscope, pathology multimedia color image and text reporting system, pathology information management system, and other equipment; We have a complete set of molecular detection equipment, including first generation sequencing machines, real-time fluorescence quantitative PCR, and supporting equipment.
The department is developing rapidly, and the number of specimens is increasing year by year. The routine pathological examination exceeded 70000 cases in 2021, ranking among the top 2 in Shenzhen. The business scope has evolved from simple biopsy and cytology to specialized staining, immunohistochemistry, renal biopsy pathology, bone marrow pathology, in situ hybridization, FISH, sequencing and other molecular pathological examinations, achieving full coverage of pathological projects.
The pathology department also carries out the following advanced technologies: since 2004, bone marrow pathology has been carried out to improve the diagnosis rate of hematological diseases; In 2008, our hospital was the first in Shenzhen to conduct renal biopsy pathology examinations. In 2021, our hospital ranked first in the city in terms of renal biopsy diagnosis volume; Director Yin Weihua was invited to participate in the compilation of the World Health Organization (WHO) Fifth Edition Classification Standards for Lymphoma and Hematopoietic System Tumors for the pathological diagnosis of lymphoma.
Taking patients as the center and quality as the core, with the goal of providing accurate, objective, and timely experimental diagnostic basis for clinical diagnosis and disease prevention and treatment, the department will further expand the connotation of pathology, strengthen laboratory management and quality control, build modern laboratories that are automated, information-based, scientific, and standardized, continue to strive to improve comprehensive technical level, and carry out new projects and methods to better serve patients.